Compare Moderna, Inc. (MRNA) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs First Trust Cloud Computing ETF — how do they compare? Moderna, Inc. trades at $219.06 (market cap $78.65B), while First Trust Cloud Computing ETF trades at $173.55 (market cap $3.47B). The key difference: Moderna, Inc. is far larger — about 22.7× First Trust Cloud Computing ETF's market cap, and First Trust Cloud Computing ETF is more actively traded (176,159 versus 37,373,437). Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and First Trust Cloud Computing ETF for 84 Days on average.
| MRNA | SKYY | |
|---|---|---|
Market Cap | $78.65B | $3.47B |
Volume | 37,373,437 | 176,159 |
Sector | Health | — |
52-Week High | $203.46 | $171.01 |
52-Week Low | $22.36 | $104.16 |
Typical Hold Time | 59 Days | 84 Days |
Enterprise Value | $74.80B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
SKYY (First Trust Cloud Computing ETF) trades at $171.75, up 0.57% today and recently hitting a new 52-week high. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. The ETF benefits from strong secular trends in cloud computing and AI infrastructure spending, with recent news highlighting institutional position adjustments and positive sector outlook.
The outlook remains positive given cloud computing's growth trajectory and AI-driven demand, though valuation metrics are unavailable for analysis. Risks include sector concentration and market volatility. Institutional activity shows mixed signals with some trimming positions while sector analysts maintain optimistic coverage on cloud computing infrastructure growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
